CN116036198A - 一种外用药膏及其制备方法 - Google Patents
一种外用药膏及其制备方法 Download PDFInfo
- Publication number
- CN116036198A CN116036198A CN202310138111.8A CN202310138111A CN116036198A CN 116036198 A CN116036198 A CN 116036198A CN 202310138111 A CN202310138111 A CN 202310138111A CN 116036198 A CN116036198 A CN 116036198A
- Authority
- CN
- China
- Prior art keywords
- parts
- ointment
- external
- external ointment
- effects
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000002674 ointment Substances 0.000 title claims abstract description 50
- 238000002360 preparation method Methods 0.000 title abstract description 14
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 claims abstract description 26
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 25
- 239000004863 Frankincense Substances 0.000 claims abstract description 22
- 239000002994 raw material Substances 0.000 claims abstract description 21
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims abstract description 18
- 241000723346 Cinnamomum camphora Species 0.000 claims abstract description 18
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims abstract description 18
- 229940116229 borneol Drugs 0.000 claims abstract description 18
- 229930008380 camphor Natural products 0.000 claims abstract description 18
- 229960000846 camphor Drugs 0.000 claims abstract description 18
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims abstract description 18
- 241000402754 Erythranthe moschata Species 0.000 claims abstract description 17
- 241000258920 Chilopoda Species 0.000 claims abstract description 16
- 206010004542 Bezoar Diseases 0.000 claims abstract description 15
- 240000007311 Commiphora myrrha Species 0.000 claims abstract description 15
- 235000006965 Commiphora myrrha Nutrition 0.000 claims abstract description 15
- 235000007265 Myrrhis odorata Nutrition 0.000 claims abstract description 15
- 235000006484 Paeonia officinalis Nutrition 0.000 claims abstract description 14
- 229910052956 cinnabar Inorganic materials 0.000 claims abstract description 14
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 14
- 235000003717 Boswellia sacra Nutrition 0.000 claims abstract description 13
- 240000007551 Boswellia serrata Species 0.000 claims abstract description 13
- 235000012035 Boswellia serrata Nutrition 0.000 claims abstract description 13
- 244000223014 Syzygium aromaticum Species 0.000 claims abstract description 12
- 235000016639 Syzygium aromaticum Nutrition 0.000 claims abstract description 12
- 241000305492 Gastrodia Species 0.000 claims abstract description 8
- 241001506766 Xanthium Species 0.000 claims description 13
- 241001106477 Paeoniaceae Species 0.000 claims description 11
- 239000009670 cang er zi wan Substances 0.000 claims description 10
- 238000002156 mixing Methods 0.000 claims description 10
- 239000000843 powder Substances 0.000 claims description 10
- 241000717739 Boswellia sacra Species 0.000 claims description 9
- 241000207929 Scutellaria Species 0.000 claims description 9
- 241000305491 Gastrodia elata Species 0.000 claims description 8
- 241000131808 Scolopendra Species 0.000 claims description 8
- 239000010238 camphora Substances 0.000 claims description 8
- 229940025250 camphora Drugs 0.000 claims description 8
- 241000628997 Flos Species 0.000 claims description 7
- 244000153234 Hibiscus abelmoschus Species 0.000 claims description 7
- 241001057584 Myrrha Species 0.000 claims description 7
- 239000000706 filtrate Substances 0.000 claims description 7
- 238000001914 filtration Methods 0.000 claims description 7
- 238000000227 grinding Methods 0.000 claims description 7
- 238000007873 sieving Methods 0.000 claims description 7
- 240000004534 Scutellaria baicalensis Species 0.000 claims description 3
- 235000017089 Scutellaria baicalensis Nutrition 0.000 claims description 3
- 238000000034 method Methods 0.000 claims 4
- 230000000694 effects Effects 0.000 abstract description 43
- 230000008961 swelling Effects 0.000 abstract description 27
- 230000001737 promoting effect Effects 0.000 abstract description 21
- 206010017553 Furuncle Diseases 0.000 abstract description 15
- 230000003902 lesion Effects 0.000 abstract description 11
- 238000005469 granulation Methods 0.000 abstract description 8
- 230000003179 granulation Effects 0.000 abstract description 8
- 239000003053 toxin Substances 0.000 abstract description 8
- 231100000765 toxin Toxicity 0.000 abstract description 8
- 239000003814 drug Substances 0.000 abstract description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 6
- 208000002474 Tinea Diseases 0.000 abstract description 4
- 241000130764 Tinea Species 0.000 abstract description 4
- 229940079593 drug Drugs 0.000 abstract description 4
- 230000001338 necrotic effect Effects 0.000 abstract description 4
- 206010016717 Fistula Diseases 0.000 abstract description 3
- 206010042674 Swelling Diseases 0.000 abstract description 3
- 230000003890 fistula Effects 0.000 abstract description 3
- 206010040872 skin infection Diseases 0.000 abstract description 2
- 241000050051 Chelone glabra Species 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 244000067505 Xanthium strumarium Species 0.000 abstract 1
- 230000003211 malignant effect Effects 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 description 24
- 230000004054 inflammatory process Effects 0.000 description 24
- 239000004480 active ingredient Substances 0.000 description 21
- 210000003491 skin Anatomy 0.000 description 18
- 241000894006 Bacteria Species 0.000 description 16
- 210000004369 blood Anatomy 0.000 description 15
- 239000008280 blood Substances 0.000 description 15
- 208000017520 skin disease Diseases 0.000 description 14
- 230000003110 anti-inflammatory effect Effects 0.000 description 13
- 208000003251 Pruritus Diseases 0.000 description 12
- 230000007803 itching Effects 0.000 description 11
- 230000002401 inhibitory effect Effects 0.000 description 10
- 230000035876 healing Effects 0.000 description 9
- 231100000331 toxic Toxicity 0.000 description 9
- 230000002588 toxic effect Effects 0.000 description 9
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 8
- 208000027418 Wounds and injury Diseases 0.000 description 8
- 230000000844 anti-bacterial effect Effects 0.000 description 8
- 230000009286 beneficial effect Effects 0.000 description 8
- 239000003921 oil Substances 0.000 description 8
- 235000019198 oils Nutrition 0.000 description 8
- 206010052428 Wound Diseases 0.000 description 7
- 230000000857 drug effect Effects 0.000 description 7
- 230000002500 effect on skin Effects 0.000 description 7
- 235000019486 Sunflower oil Nutrition 0.000 description 6
- 206010000496 acne Diseases 0.000 description 6
- 238000001816 cooling Methods 0.000 description 6
- 239000002600 sunflower oil Substances 0.000 description 6
- 230000003467 diminishing effect Effects 0.000 description 5
- 241000700605 Viruses Species 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 229960001340 histamine Drugs 0.000 description 4
- 210000000265 leukocyte Anatomy 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 231100000419 toxicity Toxicity 0.000 description 4
- 230000001988 toxicity Effects 0.000 description 4
- FXNFHKRTJBSTCS-UHFFFAOYSA-N Baicalein Natural products C=1C(=O)C=2C(O)=C(O)C(O)=CC=2OC=1C1=CC=CC=C1 FXNFHKRTJBSTCS-UHFFFAOYSA-N 0.000 description 3
- 206010007247 Carbuncle Diseases 0.000 description 3
- 206010015150 Erythema Diseases 0.000 description 3
- 208000032912 Local swelling Diseases 0.000 description 3
- IPQKDIRUZHOIOM-UHFFFAOYSA-N Oroxin A Natural products OC1C(O)C(O)C(CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IPQKDIRUZHOIOM-UHFFFAOYSA-N 0.000 description 3
- 241000191967 Staphylococcus aureus Species 0.000 description 3
- 241000194017 Streptococcus Species 0.000 description 3
- 230000003213 activating effect Effects 0.000 description 3
- UDFLTIRFTXWNJO-UHFFFAOYSA-N baicalein Chemical compound O1C2=CC(=O)C(O)=C(O)C2=C(O)C=C1C1=CC=CC=C1 UDFLTIRFTXWNJO-UHFFFAOYSA-N 0.000 description 3
- 229940015301 baicalein Drugs 0.000 description 3
- IKIIZLYTISPENI-ZFORQUDYSA-N baicalin Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IKIIZLYTISPENI-ZFORQUDYSA-N 0.000 description 3
- 229960003321 baicalin Drugs 0.000 description 3
- AQHDANHUMGXSJZ-UHFFFAOYSA-N baicalin Natural products OC1C(O)C(C(O)CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 AQHDANHUMGXSJZ-UHFFFAOYSA-N 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- 210000000601 blood cell Anatomy 0.000 description 3
- 239000010624 camphor oil Substances 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 231100000321 erythema Toxicity 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 239000012466 permeate Substances 0.000 description 3
- 238000010298 pulverizing process Methods 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 238000007670 refining Methods 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 230000017423 tissue regeneration Effects 0.000 description 3
- 230000029663 wound healing Effects 0.000 description 3
- 241001480043 Arthrodermataceae Species 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 241000736199 Paeonia Species 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 230000003266 anti-allergic effect Effects 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 210000001142 back Anatomy 0.000 description 2
- 230000007797 corrosion Effects 0.000 description 2
- 238000005260 corrosion Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000037304 dermatophytes Effects 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 239000000932 sedative agent Substances 0.000 description 2
- 230000001624 sedative effect Effects 0.000 description 2
- 206010040882 skin lesion Diseases 0.000 description 2
- 231100000444 skin lesion Toxicity 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 229940126673 western medicines Drugs 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 241001608538 Boswellia Species 0.000 description 1
- 235000018062 Boswellia Nutrition 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 208000022535 Infectious Skin disease Diseases 0.000 description 1
- 208000037273 Pathologic Processes Diseases 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 241000607764 Shigella dysenteriae Species 0.000 description 1
- 206010052891 Skin bacterial infection Diseases 0.000 description 1
- 206010040844 Skin exfoliation Diseases 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000223238 Trichophyton Species 0.000 description 1
- 241000893963 Trichophyton concentricum Species 0.000 description 1
- 241000223229 Trichophyton rubrum Species 0.000 description 1
- 241001480050 Trichophyton violaceum Species 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 241001251949 Xanthium sibiricum Species 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000035618 desquamation Effects 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 210000001061 forehead Anatomy 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 244000053095 fungal pathogen Species 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 210000003630 histaminocyte Anatomy 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000008338 local blood flow Effects 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 239000009112 niuhuang Substances 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000009054 pathological process Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 210000003371 toe Anatomy 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 208000037911 visceral disease Diseases 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
- A61K31/125—Camphor; Nuclear substituted derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/28—Mercury; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/37—Digestive system
- A61K35/413—Gall bladder; Bile
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/55—Glands not provided for in groups A61K35/22 - A61K35/545, e.g. thyroids, parathyroids or pineal glands
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/648—Myriapods, e.g. centipedes or millipedes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/285—Aucklandia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8988—Gastrodia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/35—Extraction with lipophilic solvents, e.g. Hexane or petrol ether
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Zoology (AREA)
- Virology (AREA)
- Immunology (AREA)
- Nutrition Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Insects & Arthropods (AREA)
- Neurosurgery (AREA)
- Inorganic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Gastroenterology & Hepatology (AREA)
Abstract
本发明提供一种外用药膏及其制备方法,涉及药物技术领域。一种外用药膏,包括以下原料:冰片,牛黄,乳香,没药,天麻,朱砂,丁香,赤芍,木香,苍耳子,黄芩,樟脑,香花油,蜈蚣和麝香。本发明的外用药膏具有清除内毒、祛腐生肌和消肿之效,能够帮助局部病变得到改善,达到深层治疗和修复病变部位的目的,主要用于皮肤感染类疾病,恶肿、疮、疖、瘘、癣。其制备方法操作简单,便于生产。
Description
技术领域
本发明涉及药物技术领域,具体而言,涉及一种外用药膏及其制备方法。
背景技术
中医学认为,人体内有一些疾病可以通过皮肤反映出来,很多疾病是内脏疾病的外在表现,即皮肤发生的根本原因在于阴阳失调,血垢瘀阻、毒素累积所致。但,有些皮肤病则是因真菌、皮肤细菌感染等引起。总之,皮肤病是皮肤受到内外因素的影响后,其形态、结构和功能均发生变化,发生病理过程,并相应的产生各种临床先后表现。皮肤病也是严重影响人们健康的常见病症,常见的感染类皮肤病有肿毒、疮、疖、癣等。
常用中药或西药治疗皮肤病,但是中药配方单一,具有局限性,在一定程度上达不到深层治疗的效果,因而造成治疗不彻底容易复发;西药在治疗皮肤病中不同程度的添加激素或抗生素,存在一定的毒副作用或容易产生抗体,还有部分药物达不到治疗和修复病变部位的目的。
发明内容
本发明的目的在于提供一种外用药膏,具有清除内毒、祛腐生肌和消肿之效,能够帮助局部病变得到改善,达到深层治疗和修复病变部位的目的,主要用于皮肤感染类疾病,恶肿、疮、疖、瘘、癣。
本发明的另一目的在于提供一种外用药膏的制备方法,操作简单,便于生产。
本发明解决其技术问题是采用以下技术方案来实现的。
本发明提出一种外用药膏,包括以下原料:冰片,牛黄,乳香,没药,天麻,朱砂,丁香,赤芍,木香,苍耳子,黄芩,樟脑,香花油,蜈蚣和麝香。
本发明提出一种外用药膏的制备方法,包括以下步骤:
将苍耳子破碎炒制,然后与冰片、牛黄、乳香、没药、赤芍、朱砂、天麻、丁香、木香、黄芩、蜈蚣和麝香研磨成细粉,过筛,再与樟脑和香花油混合煎炸,过滤,将滤液炼熬至粘稠状,得到药膏。
本发明实施例至少具有以下有益效果:
本发明中,组方以清除内毒、祛腐生肌和消肿为治疗原则,其中,冰片能够消炎、止痛、清热防腐,可以促进创伤后局部肿胀的消退,有助于收缩毛细血管,快速止血,促进创口快速愈合;牛黄能够清热解毒、消肿止痛,有利于减轻炎症,加快肿毒、疖、疮痊愈;乳香能够清热解毒、凉血消肿,可以促进多核白血球增加,以吞噬死亡的血球及细胞,改善新陈代谢,以增强消炎之效,还有助于生肌止痒;没药散血化瘀、抗菌;天麻镇静镇痛、抗炎、增强免疫;朱砂清热解毒、抑菌,有助于进一步加快炎症减轻,促进创面愈合;赤芍清热凉血、散瘀止痛、抑菌;木香清热解毒、消炎止痛、抗菌消炎、抗病毒;苍耳子散寒除湿、消肿止痛、抗炎抑菌;黄芩抗炎、抗过敏、抑菌;樟脑止痛止痒、消肿;香花杀菌、解毒消肿;蜈蚣抑菌、消炎、祛腐生肌;麝香活血通经、消肿止痛、抗炎、抗菌。几者配伍使用,有助于对皮肤表面及内里的细菌进行抑制,抑制组织胺释放,显著减轻炎症反应,以达到深层治疗的目的,有利于更快对局部病变部位进行修复,增强对皮肤疾病的治疗效果。
本发明中,将苍耳子先破碎炒制可以降低毒性,方便入药,以增强散风、除湿之效,提高对皮肤疾病的治疗作用。将部分原料研磨成细粉与樟脑和香花油混合煎炸时,可以让其他原料的有效成分析出溶解于香花油中,以提高溶液中有效成分的含量,后续经过炼熬后,可以提高有效成分的浓度,以增强药效。此外,经过炒制、煎炸和炼熬后,可以提高有效成分的活性,更易于有效成分渗透进皮肤病变部位,以增强药效,达到深层治疗的目的,促进肿毒、疖、疮愈合。
具体实施方式
为使本发明实施例的目的、技术方案和优点更加清楚,下面将对本发明实施例中的技术方案进行清楚、完整地描述。实施例中未注明具体条件者,按照常规条件或制造商建议的条件进行。所用试剂或仪器未注明生产厂商者,均为可以通过市售购买获得的常规产品。
需要说明的是,在不冲突的情况下,本发明中的实施例及实施例中的特征可以相互组合。下面将参考具体实施例来详细说明本发明。
一种外用药膏,包括以下原料:冰片,牛黄,乳香,没药,天麻,朱砂,丁香,赤芍,木香,苍耳子,黄芩,樟脑,香花油,蜈蚣和麝香。
冰片可以促进创伤后局部肿胀的消退,可以收缩毛细血管,快速止血。冰片中的抗菌素还具有消炎、止痛、促进创口快速愈合的功效。冰片还可以开窍散郁、清热防腐,有助于治疗痈肿疮疖等皮肤疾病。
牛黄具有清热解毒、消肿止痛之效,有助于清除内毒,减轻炎症,加快肿毒、疮等消退,有利于治疗热疖、疗疮、肿毒、痤疮等。此外,牛黄具有镇静、抗炎、抗病原微生物的作用。
乳香具有清热解毒、凉血消肿之效,可以有效治疗疮、疖、肿毒等。其可以促进多核白血球增加,以吞噬死亡的血球及细胞,改善新陈代谢,从而起消炎作用。乳香辛苦温,入脾心二经,脾主肌肉,故能生肌,苦能燥湿止痒。
没药具有抗菌作用,对堇色毛癣菌、同心性毛癣菌、许兰黄癣菌等多种致病性皮肤真菌有不同程度的抑制作用。与乳香配伍,乳香偏于行气、伸筋,没药偏于散血化瘀,可以增强治疗痈疽肿痛,疮疡溃后久不收口以及一切瘀滞痛证。
天麻有镇静、镇痛之效,天麻多糖有增强机体非特异性免疫及细胞免疫和抗炎作用。
朱砂具有清热解毒之效,可以治疗疮痈、肿毒。外用具有抑菌、减轻炎症反应、促进创面愈合等作用。与牛黄、麝香配伍,可以增强清热之效。
赤芍具有清热凉血、散瘀止痛之效,对伤寒杆菌、痢疾杆菌、金黄色葡萄球菌、溶血性链球菌、某些致病性真菌及病毒有较强抑制作用。
木香具有清热解毒、消炎止痛、抗菌消炎、抗病毒等功效,利用其清热除湿、解毒消肿的作用治疗疖疮肿毒。木香还能抑制链球菌、金黄色葡萄球菌、大肠杆菌、白喉杆菌的生长,有较强的抑菌作用,可以缓解病变部位炎症情况,促进愈合。
苍耳子具有散寒除湿之效,因其辛散温通、利血脉、消肿止痛,可减轻热毒导致的气滞不通而诱发的肿痛、疖疮初起,具有较好的抗炎作用。此外,苍耳子对金黄色葡萄球菌、肺炎球菌、乙型链球菌、红色毛癣菌有抑制之效。
黄芩具有抗炎、抗过敏等功效,其所含的黄芩甙、黄芩甙元等成分能够损害肥大细胞的酶激活系统,抑制过敏性介体的释放,可以有效抑制组织胺所导致的皮肤过敏反应。黄芩多糖和黄芩甙对人体内的革兰氏阴性菌以及皮肤皮肤真菌还有革兰氏阳性菌都有明显抑制和消除作用。黄芩甙和黄芩素等物质能抑制人体内的急性炎症反应,能抑制炎症渗出,还可以提高人体内毛细血管的通透性,抑制组织胺释放,也能让白细胞数量明显提高,以起到明显的抗炎作用。
樟脑有止痛、止痒的功效,可以改善皮肤局部血液循环,对于肿胀、疼痛具有改善作用。樟脑辛热燥烈,外用能够除湿杀虫、消肿止痒,有利于治疗癣疮等。
香花,具体为九里香花,九里香花中有多种天热成分,能消灭人体内的致病菌,也能消除人体内的炎症,能够活血化瘀,解毒消肿;还能消灭人类皮肤表面的多种真菌和皮肤炎症,缓解皮肤瘙痒疼痛。
蜈蚣能去除皮肤真菌,对葡萄球菌、念珠菌和铜绿假单胞菌有明显抑制作用,进而起到消炎祛病之效。蜈蚣还有攻毒散结之效,与冰片、麝香配伍可以起到祛腐生肌,促进疮疡愈合的作用。蜈蚣还可以用于治疗久治不愈的漏道、瘘管等。
麝香具有活血通经、消肿止痛之效,可以治疗疮痈肿毒、跌打损伤等。此外,麝香还可以起到抗炎、抗菌作用。
一种外用药膏按重量份数计包括冰片1-5份,牛黄2-7份,乳香3-10份,没药3-10份,天麻2-7份,朱砂1-5份,丁香4-12份,赤芍3-10份,木香4-12份,苍耳子3-10份,黄芩2-6份,樟脑4-12份,香花油50-60份,蜈蚣1-5份和麝香1-5份。在该配比下,各原料清热解毒、攻毒散结、消肿止痛、祛腐生肌之效相互协同,更便于治疗和修复皮肤病变部位,加快皮肤疾病的愈合。
一种外用药膏包括按重量份数计的冰片3份,牛黄4份,乳香5份,没药5份,天麻4份,朱砂3份,丁香6份,赤芍5份,木香6份,苍耳子5份,黄芩4份,樟脑6份,香花油55份,蜈蚣2份和麝香2份。该配比下,原料药效相互促进,可以进一步加快皮肤痊愈。
一种外用药膏的制备方法,包括以下步骤:
将苍耳子破碎炒制,在90-120℃炒制20-40min,然后与冰片、牛黄、乳香、没药、赤芍、朱砂、天麻、丁香、木香、黄芩、蜈蚣和麝香研磨成细粉,过筛,再与樟脑和香花油混合煎炸,在70-90℃煎炸10-30min,过滤,将滤液炼熬至粘稠状,在50-70℃炼熬30-60min,得到药膏。
将苍耳子先破碎炒制可以降低毒性,方便入药,以增强散风、除湿之效,提高对皮肤疾病的治疗作用。将部分原料研磨成细粉与樟脑和香花油混合煎炸时,可以让其他原料的有效成分析出溶解于香花油中,以提高溶液中有效成分的含量,后续经过炼熬后,可以提高有效成分的浓度,以增强药效。此外,经过炒制、煎炸和炼熬后,可以提高有效成分的活性,更易于有效成分渗透进皮肤病变部位,以增强药效,达到深层治疗的目的,促进肿毒、疖、疮愈合。在上述操作条件下,各原料的有效成分能够较为充分的析出,同时利于提高有效成分在药膏中的均一性,有利于提高有效成分的活性,以增强对皮肤疾病的治疗效果。
使用时,先清洁病变部位,擦干水分,取适量外用药膏涂抹于病变部位,覆盖病变部位为止,每天使用两次,每次使用前需要清洗或擦拭病变部位,用药期间,忌辛辣、酒等。
以下结合实施例对本发明的特征和性能作进一步的详细描述。
实施例1
一种外用药膏的制备方法,包括以下步骤:
原料:冰片3g,牛黄4g,乳香5g,没药5g,天麻4g,朱砂3g,丁香6g,赤芍5g,木香6g,苍耳子5g,黄芩4g,樟脑6g,香花油55g,蜈蚣2g和麝香2g;
将苍耳子破碎炒制,在100℃炒制30min,然后与冰片、牛黄、乳香、没药、赤芍、朱砂、天麻、丁香、木香、黄芩、蜈蚣和麝香研磨成细粉,过筛,再与樟脑和香花油混合煎炸,在80℃煎炸20min,过滤,将滤液炼熬至粘稠状,在60℃炼熬40min,得到药膏。
实施例2
一种外用药膏的制备方法,包括以下步骤:
原料:冰片1g,牛黄2g,乳香3g,没药3g,天麻2g,朱砂1g,丁香4g,赤芍3g,木香4g,苍耳子3g,黄芩2g,樟脑4g,香花油50g,蜈蚣1g和麝香1g;
将苍耳子破碎炒制,在90℃炒制20min,然后与冰片、牛黄、乳香、没药、赤芍、朱砂、天麻、丁香、木香、黄芩、蜈蚣和麝香研磨成细粉,过筛,再与樟脑和香花油混合煎炸,在70℃煎炸10min,过滤,将滤液炼熬至粘稠状,在50℃炼熬30min,得到药膏。
实施例3
一种外用药膏的制备方法,包括以下步骤:
原料:冰片2g,牛黄6g,乳香6g,没药7g,天麻4g,朱砂3g,丁香10g,赤芍8g,木香8g,苍耳子8g,黄芩5g,樟脑8g,香花油55g,蜈蚣3g和麝香3g;
将苍耳子破碎炒制,在110℃炒制35min,然后与冰片、牛黄、乳香、没药、赤芍、朱砂、天麻、丁香、木香、黄芩、蜈蚣和麝香研磨成细粉,过筛,再与樟脑和香花油混合煎炸,在85℃煎炸15min,过滤,将滤液炼熬至粘稠状,在65℃炼熬45min,得到药膏。
实施例4
一种外用药膏的制备方法,包括以下步骤:
原料:冰片5g,牛黄7g,乳香10g,没药10g,天麻7g,朱砂5g,丁香12g,赤芍10g,木香12g,苍耳子10g,黄芩6g,樟脑12g,香花油60g,蜈蚣5g和麝香5g;
将苍耳子破碎炒制,在120℃炒制40min,然后与冰片、牛黄、乳香、没药、赤芍、朱砂、天麻、丁香、木香、黄芩、蜈蚣和麝香研磨成细粉,过筛,再与樟脑和香花油混合煎炸,在90℃煎炸30min,过滤,将滤液炼熬至粘稠状,在70℃炼熬60min,得到药膏。
典型案例
1、李某,男,25岁,左足趾间瘙痒伴有小丘疹、水疱,未予治疗,2月后,突发患足背、小腿红肿、疼痛,左足趾间针头大小丘疹,水疱伴有轻度糜烂,右足正常。左足背至胫前大片红斑,轻度肿胀,紧张发亮,可见张力性小水疱,皮温高。使用本发明实施例1的外用药膏,取适量涂抹于患处,每天两次,使用半月后,症状明显消失,继续使用半月后,痊愈。
2、方某,男,20岁,全身瘙痒月余,皮损以腹部、大腿内侧较为明显,表现为散在的针头大小红色或皮色丘疹,部分结痂少许渗出,手指间渗出明显。使用本发明实施例1的外用药膏,取适量涂抹于患处,每天两次,使用20天后,症状消失。
3、付某,男,40岁,面部热疖,上有黄白色脓头,伴有自行抓破结痂,疖色红,偶有局部疼痛,以前额、两颊、口唇周围居多,偶有头部热疖。使用本发明实施例2的外用药膏,取适量涂抹于患处,每天两次,使用30天后,症状消失。
4、刘某,女,35岁,被不明物体蜇伤,刺痛难忍,后续出现了双下肢一下皮肤红色丘疹,溃烂渗水,瘙痒难忍。使用本发明实施例3的外用药膏,取适量涂抹于患处,每天两次,使用7天后,无瘙痒,有红色丘疹,无渗水,继续使用7天后,红色丘疹消失,创面愈合。
5、华某,女,25岁,一月前无明显诱因下,胳膊出现小片红斑,伴有瘙痒,间隔几天后,红斑范围逐渐扩大,且表面有少许脱屑,瘙痒难忍。使用本发明实施例4的外用药膏,取适量涂抹于患处,每天两次,使用20天后,症状消失。
综上所述,本发明实施例的外用药膏,组方以清除内毒、、祛腐生肌和消肿为治疗原则,其中,冰片能够消炎、止痛、清热防腐,可以促进创伤后局部肿胀的消退,有助于收缩毛细血管,快速止血,促进创口快速愈合;牛黄能够清热解毒、消肿止痛,有利于减轻炎症,加快肿毒、疖、疮痊愈;乳香能够清热解毒、凉血消肿,可以促进多核白血球增加,以吞噬死亡的血球及细胞,改善新陈代谢,以增强消炎之效,还有助于生肌止痒;没药散血化瘀、抗菌;天麻镇静镇痛、抗炎、增强免疫;朱砂清热解毒、抑菌,有助于进一步加快炎症减轻,促进创面愈合;赤芍清热凉血、散瘀止痛、抑菌;木香清热解毒、消炎止痛、抗菌消炎、抗病毒;苍耳子散寒除湿、消肿止痛、抗炎抑菌;黄芩抗炎、抗过敏、抑菌;樟脑止痛止痒、消肿;香花杀菌、解毒消肿;蜈蚣抑菌、消炎、祛腐生肌;麝香活血通经、消肿止痛、抗炎、抗菌。几者配伍使用,有助于对皮肤表面及内里的细菌进行抑制,抑制组织胺释放,显著减轻炎症反应,以达到深层治疗的目的,有利于更快对局部病变部位进行修复,增强对皮肤疾病的治疗效果。
本发明实施例的外用药膏的制备方法,将苍耳子先破碎炒制可以降低毒性,方便入药,以增强散风、除湿之效,提高对皮肤疾病的治疗作用。将部分原料研磨成细粉与樟脑和香花油混合煎炸时,可以让其他原料的有效成分析出溶解于香花油中,以提高溶液中有效成分的含量,后续经过炼熬后,可以提高有效成分的浓度,以增强药效。此外,经过炒制、煎炸和炼熬后,可以提高有效成分的活性,更易于有效成分渗透进皮肤病变部位,以增强药效,达到深层治疗的目的,促进肿毒、疖、疮愈合。在上述操作条件下,各原料的有效成分能够较为充分的析出,同时利于提高有效成分在药膏中的均一性,有利于提高有效成分的活性,以增强对皮肤疾病的治疗效果。
以上所描述的实施例是本发明一部分实施例,而不是全部的实施例。本发明的实施例的详细描述并非旨在限制要求保护的本发明的范围,而是仅仅表示本发明的选定实施例。基于本发明中的实施例,本领域普通技术人员在没有作出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。
Claims (7)
1.一种外用药膏,其特征在于,包括以下原料:冰片,牛黄,乳香,没药,天麻,朱砂,丁香,赤芍,木香,苍耳子,黄芩,樟脑,香花油,蜈蚣和麝香。
2.根据权利要求1所述的外用药膏,其特征在于,按重量份数计,包括冰片1-5份,牛黄2-7份,乳香3-10份,没药3-10份,天麻2-7份,朱砂1-5份,丁香4-12份,赤芍3-10份,木香4-12份,苍耳子3-10份,黄芩2-6份,樟脑4-12份,香花油50-60份,蜈蚣1-5份和麝香1-5份。
3.根据权利要求2所述的外用药膏,其特征在于,包括按重量份数计的冰片3份,牛黄4份,乳香5份,没药5份,天麻4份,朱砂3份,丁香6份,赤芍5份,木香6份,苍耳子5份,黄芩4份,樟脑6份,香花油55份,蜈蚣2份和麝香2份。
4.一种如权利要求1-3任一项所述的外用药膏的制备方法,其特征在于,包括以下步骤:
将苍耳子破碎炒制,然后与冰片、牛黄、乳香、没药、赤芍、朱砂、天麻、丁香、木香、黄芩、蜈蚣和麝香研磨成细粉,过筛,再与樟脑和香花油混合煎炸,过滤,将滤液炼熬至粘稠状,得到药膏。
5.根据权利要求4所述的外用药膏的制备方法,其特征在于,在90-120℃炒制20-40min。
6.根据权利要求4所述的外用药膏的制备方法,其特征在于,在70-90℃煎炸10-30min。
7.根据权利要求4所述的外用药膏的制备方法,其特征在于,在50-70℃炼熬30-60min。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310138111.8A CN116036198A (zh) | 2023-02-20 | 2023-02-20 | 一种外用药膏及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310138111.8A CN116036198A (zh) | 2023-02-20 | 2023-02-20 | 一种外用药膏及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116036198A true CN116036198A (zh) | 2023-05-02 |
Family
ID=86129949
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310138111.8A Withdrawn CN116036198A (zh) | 2023-02-20 | 2023-02-20 | 一种外用药膏及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116036198A (zh) |
-
2023
- 2023-02-20 CN CN202310138111.8A patent/CN116036198A/zh not_active Withdrawn
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100350951C (zh) | 一种治疗烧创伤及局部肿块炎症的外用药 | |
CN108295089A (zh) | 一种超微和田玉粉的制备方法及其应用 | |
CN102068576B (zh) | 痔疮膏 | |
CN100455311C (zh) | 一种用于烧、烫伤治疗及祛痘产品的中药组合物及其制备方法 | |
CN101049466A (zh) | 烧烫伤无痛无疤痕治疗中草药膏及其制备方法 | |
CN113616714A (zh) | 一种高硒抗hpv病毒的生物蛋白凝胶敷料及其制备方法 | |
CN102861217A (zh) | 一种治疗疔疮疖痈的外贴膏剂 | |
CN111067971A (zh) | 一种治疗甲沟炎的中药组合物及其使用方法 | |
CN1189197C (zh) | 一种具有消炎止血止痛活血生肌的中药 | |
CN106822321B (zh) | 伤科黄水在制备治疗毛周角化症的药物中的应用 | |
CN116036198A (zh) | 一种外用药膏及其制备方法 | |
CN113181318A (zh) | 一种治疗痔疮的中药药膏及其制备方法 | |
CN111544523A (zh) | 一种治疗皮肤溃烂的中药组合物及其应用 | |
CN110624032A (zh) | 一种治疗烧烫伤的膏剂及其制备方法 | |
CN104352599A (zh) | 一种治疗烧烫伤的中药组合物 | |
CN104984070A (zh) | 一种烫伤药 | |
CN110227109B (zh) | 一种用于猪慢性湿疹的组合物及其制备方法 | |
CN115414415B (zh) | 一种治疗皮肤外伤及溃烂的中药组合物及制备方法 | |
CN108066466A (zh) | 一种治疗烧烫伤的中药组合物及其制备方法与应用 | |
CN109331106B (zh) | 用于创面修复的红药制剂及其制备方法 | |
CN1069038C (zh) | 跌打万应膏及其制备方法 | |
CN106692491B (zh) | 一种祛除烫烧伤疤痕的药膏 | |
CN1084748A (zh) | 速效关节炎敷剂及其制造方法 | |
CN106166201A (zh) | 一种治疗疮疡的中药膏 | |
CN105343390A (zh) | 一种治疗神经内科周围神经肌肉疾病的膏方 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20230502 |
|
WW01 | Invention patent application withdrawn after publication |